These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 29462707

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome.
    Caanen MR, Peters HE, van de Ven PM, Jüttner AMFM, Laven JSE, van Hooff MHA, Lambalk CB.
    J Clin Endocrinol Metab; 2021 Mar 08; 106(3):e1084-e1095. PubMed ID: 33351079
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1716-1722. PubMed ID: 28854589
    [Abstract] [Full Text] [Related]

  • 6. Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism.
    Park AS, Lawson MA, Chuan SS, Oberfield SE, Hoeger KM, Witchel SF, Chang RJ.
    J Clin Endocrinol Metab; 2010 Apr 01; 95(4):1786-92. PubMed ID: 20150576
    [Abstract] [Full Text] [Related]

  • 7. Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.
    Pelusi C, Fanelli F, Pariali M, Zanotti L, Gambineri A, Pasquali R.
    J Clin Endocrinol Metab; 2013 Oct 01; 98(10):E1575-82. PubMed ID: 23928669
    [Abstract] [Full Text] [Related]

  • 8. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 9. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.
    Akush Ginekol (Sofiia); 2014 Aug 01; 53(5):22-7. PubMed ID: 25558667
    [Abstract] [Full Text] [Related]

  • 10. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Aug 01; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Do the Anti-Müllerian Hormone Levels of Adolescents with Polycystic Ovary Syndrome, Those Who Are at Risk for Developing Polycystic Ovary Syndrome, and Those Who Exhibit Isolated Oligomenorrhea Differ from Those of Adolescents with Normal Menstrual Cycles?
    Savas-Erdeve S, Keskin M, Sagsak E, Cenesiz F, Cetinkaya S, Aycan Z.
    Horm Res Paediatr; 2016 Aug 01; 85(6):406-11. PubMed ID: 27173790
    [Abstract] [Full Text] [Related]

  • 13. Effect of the presence of polycystic ovary syndrome-related features on anti-Mullerian hormone and androstenedione levels in adolescents with or without menstrual irregularity.
    Hanedan N, Ersoy B, Hanedan C, Ozyurt BC, Taneli F.
    Arch Gynecol Obstet; 2022 Aug 01; 306(2):523-531. PubMed ID: 35355114
    [Abstract] [Full Text] [Related]

  • 14. The relationship between Anti-Müllerian hormone and other reproductive parameters in normal women and in women with polycystic ovary syndrome.
    Koutlaki N, Dimitraki M, Zervoudis S, Poiana C, Psillaki A, Nikas I, Liberis A, Badiu C, Liberis V.
    J Med Life; 2013 Jun 15; 6(2):146-50. PubMed ID: 23904873
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D, Alebić MŠ, Duhamel A, Stojanović N.
    Hum Reprod; 2014 Nov 15; 29(11):2536-43. PubMed ID: 25267785
    [Abstract] [Full Text] [Related]

  • 18. Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome.
    Matsuzaki T, Munkhzaya M, Iwasa T, Tungalagsuvd A, Yano K, Mayila Y, Yanagihara R, Tokui T, Kato T, Kuwahara A, Matsui S, Irahara M.
    Endocr J; 2017 May 30; 64(5):531-541. PubMed ID: 28381699
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents.
    Villarroel C, López P, Merino PM, Iñiguez G, Sir-Petermann T, Codner E.
    Gynecol Endocrinol; 2015 May 30; 31(8):625-9. PubMed ID: 26190534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.